Chapter 14 Outline

• Jurisdiction: United States

Chapter 14

Analytical Framework for Patent Infringement

§14.01 Statutory Basis: 35 U.S.C. §271

§14.02 Direct Versus Indirect Infringement

[A] Introduction

[B] Direct Infringement Under §271(a)

[1] Making

[2] Using

[a] Generally

[b] Using a Claimed System

[c] Using a Claimed Method

[3] Selling

[4] Offering to Sell

[5] Importing

§14.03 Territoriality Aspects of §271(a)

[A] Introduction

[B] Use of Processes or Methods Within the United States

[C] "Beneficial Use" Doctrine

[D] "Sells" Within the United States

[E] "Offer[] to Sell" Within the United States

§14.04 Temporal Aspects of §271

[A] Pre-Issuance Acts

[B] Post-Issuance Acts

§14.05 Divided Direct Infringement by Multiple Entities

[A] Introduction

[B] Akamai II (Fed. Cir. 2012) ( en banc)

[C] Akamai III (U.S. 2014)

[D] Akamai V (Fed. Cir. 2015) ( en banc)

[1] "Directs or Controls" Liability

[a] Service Provider-Customer Relationship

[b] Physician-Patient Relationship

[c] "Partnership-Like" Relationship

[2] Joint Enterprise Liability

[3] Subsequent History

[E] Pleading Joint (or "Divided") Direct Infringement

[1] Illustrative Cases Not Alleging Sufficient Facts for a "Plausible" Claim

[2] Illustrative Cases That Do Allege Sufficient Facts for a "Plausible" Claim

§14.06 Indirect Infringement Under §271(b)–(c): Overview

[A] Practicing Less Than Complete Claimed Invention

[B] Intent Required

[C] Historical Background

[D] Direct Infringement as Predicate to Indirect Liability

§14.07 Two-Step Analysis for Patent Infringement